{"id":"acyclovir-in-me-609-vehicle","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":{"chemblId":"CHEMBL2108661","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Acyclovir works by selectively inhibiting viral DNA polymerase, which is essential for viral replication. This results in the inhibition of viral DNA synthesis and ultimately, the reduction of viral replication. Acyclovir is a nucleoside analog that is selectively phosphorylated by viral thymidine kinase, which then acts as a prodrug to inhibit viral DNA polymerase.","oneSentence":"Acyclovir is an antiviral medication that inhibits viral DNA synthesis by inhibiting viral DNA polymerase.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:59:21.611Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Herpes simplex virus infections"},{"name":"Varicella-zoster virus infections"},{"name":"Herpes zoster"}]},"trialDetails":[{"nctId":"NCT00361881","phase":"PHASE3","title":"Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis","status":"COMPLETED","sponsor":"Medivir","startDate":"2006-07","conditions":"Herpes Labialis","enrollment":1443},{"nctId":"NCT00735761","phase":"PHASE3","title":"Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients","status":"COMPLETED","sponsor":"Medivir","startDate":"2006-12","conditions":"Herpes Labialis","enrollment":201},{"nctId":"NCT00736437","phase":"PHASE2","title":"Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis","status":"COMPLETED","sponsor":"Medivir","startDate":"1999-08","conditions":"Herpes Labialis","enrollment":417}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"acyclovir in ME-609 vehicle","genericName":"acyclovir in ME-609 vehicle","companyName":"Medivir","companyId":"medivir","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Acyclovir is an antiviral medication that inhibits viral DNA synthesis by inhibiting viral DNA polymerase. Used for Herpes simplex virus infections, Varicella-zoster virus infections, Herpes zoster.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}